Literature Review: Analisis Target Molekuler Dan Pendekatan Kimia Medisinal Dalam Pengembangan Terapi Kanker Servik
DOI:
https://doi.org/10.55606/jurrikes.v5i2.9033Keywords:
Cervical cancer, Blood Pressure, Molecular targets, medicinal chemistry, In silico approachesAbstract
Cervical cancer is one of the most common cancers worldwide and is largely caused by Human Papillomavirus (HPV) infection, particularly types 16 and 18. The development of this cancer is influenced by the E6 and E7 oncoproteins, which disrupt the function of p53 and Rb proteins, as well as the involvement of cellular signaling pathways such as PI3K/AKT/mTOR and EGFR. Limitations of conventional therapies, such as resistance and side effects, drive the need for more targeted and selective therapeutic agents. This study aims to analyze the main molecular targets of cervical cancer and the medicinal chemistry approaches used in its therapeutic development. The method involved a review of 12 open access articles using molecular docking, molecular dynamics, QSAR, and network pharmacology approaches. The findings identified two main target groups: viral targets comprising the HPV E6 and E7 oncoproteins, and cellular targets including the PI3K/AKT/mTOR pathway, EGFR, PARP1, CDK1, and VEGFR. Various medicinal chemistry strategies, from structure-based and ligand-based drug design to multi-target network pharmacology approaches, proved effective in identifying potential inhibitor candidates. Bioactive compounds such as quercetin, gossypol, bixin, and rutin demonstrated stable interactions with these targets. However, further experimental validation is needed to support the development of clinically effective and safe therapies.
Downloads
References
Aarthy, M., Muthuramalingam, P., Ramesh, M., & Singh, S. K. (2022). Unraveling the multi-targeted curative potential of bioactive molecules against cervical cancer through integrated omics and systems pharmacology approach. Scientific Reports, 12(1), 1–19. https://doi.org/10.1038/s41598-022-18358-7
Ahmadi, M., Abdollahi, R., Otogara, M., & Taherkhani, A. (2024). Exploring molecular targets: herbal isolates in cervical cancer therapy. Genomics and Informatics, 22(1), 1–16. https://doi.org/10.1186/s44342-024-00008-1
Akash, S., Bayıl, I., Hossain, M. S., Islam, M. R., Hosen, M. E., Mekonnen, A. B., Nafidi, H. A., Bin Jardan, Y. A., Bourhia, M., & Bin Emran, T. (2023). Novel computational and drug design strategies for inhibition of human papillomavirus-associated cervical cancer and DNA polymerase theta receptor by Apigenin derivatives. Scientific Reports, 13(1), 1–22. https://doi.org/10.1038/s41598-023-43175-x
Amin, S., Pratama, D. E., Farmasi, ), Bakti, U., & Husada, T. (2025). PERAN KIMIA MEDISINAL DALAM PENGEMBANGAN OBAT ANTIKANKER: PENDEKATAN KOMPUTASI DAN EKSPLORASI SENYAWA BIOAKTIF DARI SUMBER ALAM. Indonesian Journal of Science, 1(6), 1356–1361.
Amin, S., Pujiyani, D., Rusiyana, N. P., & Azzahra, S. M. (2024). Evaluasi Potensi Antikanker Senyawa Daun Kelor melalui Kimia Medisinal. Jurnal Ilmu Medis Indonesia, 4(1), 75–82. https://doi.org/10.35912/jimi.v4i1.4544
Amin, S., Sheryl, V. A., Aprillia, A. Y., & Pebiansyah, A. (2025). Kelor (Moringa oleifera) Bioactive Compounds as Potential Anti-Breast Cancer Agents: In Silico Studies. Borneo Journal of Pharmacy, 8(4), 353–367. https://doi.org/10.33084/bjop.v8i4.7435
Amin, S., Syarifah, S. N., Illavana, N., & Diva, A. J. (2025). Evolusi Kimia Medisinal Pendekatan Berbasis Alam Dalam Penemuan Obat: Tinjauan Kimia Medisinal Program Studi S1 Farmasi, Universitas bakti Tunas Husada, Tasikmalaya Indonesia. In Journal of Innovative and Creativity (Vol. 5, Issue 4).
Amin, S., Wihdatunnisa, I., Aisyah, R., & Kurniawan, Y. S. (2024). Potensi Senyawa Kuersetin sebagai Antikanker Payudara melalui Pendekatan Molecular Docking. Jurnal Ilmu Medis Indonesia, 4(1), 41–51. https://doi.org/10.35912/jimi.v4i1.4565
Damara, F. A. (2017). CRISPR/Cas9 dengan Dual-sgRNAs Bertarget Gen E6 dan E7 Virus HPV 16 Sebagai Inovasi Terapi Gen Upaya Menurunkan Angka Kanker Serviks Global. Jurnal Scientific Pinisi, 3(2), 98–103.
Duenas-Gonzalez, A., Serrano-Olvera, A., Cetina, L., & Coronel, J. (2014). New molecular targets against cervical cancer. International Journal of Women’s Health, 6, 1023–1031. https://doi.org/10.2147/IJWH.S49471
Fera, N. (2023). Kanker Serviks. GALENICAL: Jurnal Kedokteran Dan Kesehatan Mahasiswa Malikussaleh, 2(1), 45–56.
Iqbal, A., Ali, F., Choudhary, S., Qayyum, A., Arshad, F., Ashraf, S., Aziz, M., Shakil, A. U., Sehgal, S. A., Hussain, M., & Sajid, M. (2023). in Silico Analysis of Anti-Cervical Cancer Drug Off-Target Effects on Diverse Protein Isoforms for Enhanced Therapeutic Strategies. Innovative Biosystems and Bioengineering, 7(4), 36–47. https://doi.org/10.20535/ibb.2023.7.4.288017
Jamal, J., Musnina, W. O. S. M., Setiawan, M. R. S., & Rumi, A. (2025). Uji Network Pharmacology Dan Docking Moleculer Senyawa Metabolit Sekunder Begonia willemii Endemik Sulawesi Tengah Terhadap Reseptor Kanker Serviks. Borneo Journal of Pharmascientech, 9(1), 144–162. https://doi.org/10.59053/bjp.v9i1.645
Kori, M., & Arga, K. Y. (2018). Potential biomarkers and therapeutic targets in cervical cancer. PLoS ONE, 13(7), 1–27.
Li, J., Asat, R., Li, W., Parhat, P., Ma, Y., Ma, Y., & Li, M. (2025). Molecular Target Identification of Gossypol Against Cervical Cancer Based on Target Fishing Technology. Pharmaceutics, 17(7), 1–17. https://doi.org/10.3390/pharmaceutics17070861
Pratama, J. P., Kurniawati, N., & Erikania, S. (2023). UJI IN SILICO SENYAWA DAUN BELIMBING WULUH (Averrhoa bilimbi L.) SEBAGAI ANTIKANKER KOLOREKTAL SERTA PREDIKSI PROFIL FARMAKOKINETIK DAN TOKSISITAS. Prosiding Seminar Informasi Kesehatan Nasional (SIKesNas), 2019, 2023. https://www.ojs.udb.ac.id/index.php/sikenas/article/view/2823
Saeful Amin, Alfi Nurul Aini, Nandita Marsya Putri Utami, & Dini Aryani. (2025). Kimia Medisinal dalam Terapi Kanker : Analisis Jalur Sinyal dan Interaksi Ligand-Target. Jurnal Riset Rumpun Ilmu Kesehatan, 4(1), 52–62. https://doi.org/10.55606/jurrikes.v4i1.4385
Younas, S., Malik, Z. I., Khan, M. U., Manzoor, S., Rehman, H. M., Hammad, H. M., & Akter, S. (2025). Identification of novel therapeutic inhibitors against E6 and E7 oncogenes of HPV-16 associated with cervical cancer. Plos One, 20(10 October), 1–20. https://doi.org/10.1371/journal.pone.0323595
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Saeful Amin, Aliya Fayyaza Khairun Nisa, Shilvia Siti Nurohmah, Salla Sabillah
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
_001.jpg)
